Overview

Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel

Status:
Withdrawn
Trial end date:
2019-02-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this pilot study is to conduct a controlled comparison of the efficacy and safety of a combination peel (glycolic acid and salicylic acid) as compared to glycolic acid peel alone in the treatment of melasma. Our primary outcome is objective improvement in pigmentation as evaluated using a colorimeter. Our secondary outcomes are subjective improvement using the Melasma Area and Severity Index (MASI) and Patient and Physician Global assessment, as well as assessment of treatment tolerability and patient satisfaction.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Boston Medical Center
Treatments:
Glycolic acid
Salicylates
Salicylic Acid
Criteria
Inclusion Criteria:

- Female and males aged 18 or older

- Subjects with melasma on both sides of the face (forehead or cheek).

- Subjects in general good health

- Female of childbearing age will be on a reliable form of contraception during the
course of treatment other than oral contraceptive pills or hormonal intrauterine
device.

- Subjects must be willing to sign consent, answer questionnaires, comply with all
clinical visits, and use sunscreen and sun-protection.

- Subjects must be willing to not apply other treatment options for melasma during the
course of the study

Exclusion Criteria:

- Subjects suffering from other pigmentation disorders.

- Subjects with known allergy to any components of the peels

- Subjects who have active uncontrolled disease to facial area (i.e acne).

- Pregnant women, nursing mothers.

- Subjects with history of abnormal scaring

- Subjects who cannot communicate with investigators or who are unlikely to cooperate.

- Subjects in a situation in which in the opinion of the investigators, may interfere
with optimal participation in the study.

- Subjects who have used chemical peels, microdermabrasion or facial laser treatments in
the past 3 months.